Imbalance between Pro- and Anti-inflammatory cytokines, and between Th1 and Th2 cytokines in depressed patients: The effect of electroacupuncture or fluoxetine treatment

Pharmacopsychiatry

Volumn 42, Issue 5, 2009, Pages 182-188

  Song, C ^a   Halbreich, U ^b   Han, C ^c   Leonard, B E ^d   Luo, H ^c  

^a UNIVERSITY OF PRINCE EDWARD ISLAND   (Canada)

^b UNIVERSITY AT BUFFALO   (United States)

^c PEKING UNIVERSITY SIXTH HOSPITAL   (China)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; FLUOXETINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; PLACEBO; TUMOR NECROSIS FACTOR ALPHA; ANTIDEPRESSANT AGENT; IL10 PROTEIN, HUMAN; IL4 PROTEIN, HUMAN;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ELECTROACUPUNCTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; OUTPATIENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TH1 CELL; TH2 CELL; ANALYSIS OF VARIANCE; BLOOD; IMMUNOLOGY;

ADULT; ANALYSIS OF VARIANCE; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CYTOKINES; DEPRESSIVE DISORDER, MAJOR; ELECTROACUPUNCTURE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUOXETINE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTERLEUKIN-4; MALE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70350488711     PISSN: 01763679     EISSN: 14390795     Source Type: Journal    
DOI: 10.1055/s-0029-1202263     Document Type: Article

References (57)

1. Licinio J, Wong ML. The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection. Mol Psychiatry 1999 4 317-427
2. Maes M, Smith R, Scharpe S. The monocyte-T-lymphocyte hypothesis of major depression. Psychoneuroendocrinology 1995 20 111-116
3. Bry K, Teramo K, Lappalainen U, etal. Interleukin-1 receptor antagonist in the fetomaternal compartment. Acta Paediatr 1995 84 233-236
4. Song C, Lin A, Bonaccorso S, etal. The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression. J Affect Disord 1998 49 211-219
5. Cassidy EM, Manning D, Byrne S, etal. Acute effects of low-dose interferon-alpha on serum cortisol and plasma interleukin-6. Psychopharmacol 2002 16 230-234
6. Hirschfeld RMA, Goodwin FK. Mood disorders. In Textbook of Psychiatry (eds: Talbott JA, Hales RE, Yudofsky SC) Washington: American Psychiatric Press 1988
7. Capuron L, Ravaud A, Dantzer R. Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapy. J Clin Oncol 2000 18 2143-2151
8. Meyers CA. Mood and cognitive disorders in cancer patients receiving cytokine therapy. Adv Exp Med Biol 1999 461 75-81
9. Maes M, Bosmans E, Suy E, etal. Depression-related disturbances in mitogen-induced lymphocyte responses and interleukin-1 beta and soluble interleukin-2 receptor production. Acta Psychiatr Scand 1991 84 379-386
10. Fearon DT, Locksley RM. The instructive role of innate immunity in the acquired immune response. Science 1996 272 50-53
11. Maes M, Bosmans E, Jongh R De, etal. Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine 1997 9 853-858
12. Nassberger L, Traskman-Bendz L. Increased soluble interleukin-2 receptor concentrations in suicide attempters. Acta Psychiatr Scand 1993 88 48-52
13. Connor TJ, Song C, Leonard BE, etal. An assessment of the effects of central interleukin-1beta, -2, -6, and tumor necrosis factor-alpha administration on some behavioural, neurochemical, endocrine and immune parameters in the rat. Neuroscience 1998 84 923-933
14. Song C, Leonard BE, Horrobin DF. Dietary ethyl-eicosapentaenoic acid but not soybean oil reverses central interleukin-1-induced changes in behavior, corticosterone and immune response in rats. Stress 2004 7 43-54
15. Hamilton A. A rating scale for depression. J Neural Neurosurge Psychiatry 1960 23 56-62
16. Li QQ, Bever CT. Th1 cytokines stimulate RANTES chemokine secretion by human astroglial cells depending on de novo transcription. Neurochem Res 2001 26 125-133
17. National Institute of Mental Health. CGI: Clinical Global Impression. In: Manual 40 ECDEU Assessment Battery, Volume 2 revised edition Guy, W.: Bonatorr (Editors), NIMH, Chevy Chase MD 1970 21-26
18. Salem ML. Estrogen, a double-edged sword: modulation of TH1- and TH2-mediated inflammations by differential regulation of TH1/TH2 cytokine production. Curr Drug Targets Inflamm Allergy 2004 3 97-104
19. Schwarz MJ, Chiang S, Muller N, etal. T-helper-1 and T-helper-2 responses in psychiatric disorders. Brain Behav Immun 2001 15 340-370
20. Pavon L, Sandoval-Lopez G, Eugenia Hernandez M, etal. Th2 cytokine response in Major Depressive Disorder patients before treatment. J Neuroimmunol 2006 172 156-165
21. Myint AM, Leonard BE, Steinbusch HW, etal. Th1, Th2, and Th3 cytokine alterations in major depression. J Affect Disord 2005 88 167-173
22. Ravindran AV, Griffiths J, Merali Z, etal. Lymphocyte subsets associated with major depression and dysthymia: modification by antidepressant treatment. Psychosom Med 1995 57 555-563
23. Sluzewska A, Rybakowski JK, Laciak M, etal. Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine. Ann N Y Acad Sci 1995 762 474-476
24. Maes M, Song C, Lin AH, etal. Negative immunoregulatory effects of antidepressants: inhibition of interferon-gamma and stimulation of interleukin-10 secretion. Neuropsychopharmacology 1999 20 370-379
25. Xia Z, DePierre JW, Nassberger L. Tricyclic antidepressants inhibit IL-6, IL-1 beta and TNF-alpha release in human blood monocytes and IL-2 and interferon-gamma in T cells. Immunopharmacology 1996 34 27-37
26. Chang FC, Tsai HY, Yu MC, etal. The central serotonergic system mediates the analgesic effect of electroacupuncture on ZUSANLI (ST36) acupoints. J Biomed Sci 2004 11 179-185
27. Ma QP, Zhou Y, Yu YX, etal. Electroacupuncture accelerated the expression of c-fos protooncogene in serotonergic neurons of nucleus raphe dorsalis. Int J Neurosci 1992 67 111-117
28. Song C, Chen RY. The effect of acupuncture on the uptake of [3H]-5-HT in the raphe nuclei of midbrain of adult and aging rats. J Tsinghua University (China) 1992 31 78-83
29. Yano T, Kato B, Fukuda F, etal. Alterations in the function of cerebral dopaminergic and serotonergic systems following electroacupuncture and moxibustion applications: possible correlates with their antistress and psychosomatic actions. Neurochem Res 2004 29 283-293
30. Mendlovic S, Mozes E, Eilat E, etal. Immune activation in non-treated suicidal major depression. Immunol Lett 1999 67 105-108
31. Brambilla F, Maggioni M. Blood levels of cytokines in elderly patients with major depressive disorder. Acta Psychiatr Scand 1998 97 309-313
32. Natelson BH, Denny T, Zhou XD, etal. Is depression associated with immune activation? J Affect Disord 1999 53 179-184
33. Owen BM, Eccleston D, Ferrier IN, etal. Raised levels of plasma interleukin-1beta in major and postviral depression. Acta Psychiatr Scand 2001 103 226-228
34. Schlatter J, Ortuno F, Cervera-Enguix S. Monocytic parameters in patients with dysthymia versus major depression. J Affect Disord 2004 78 243-247
35. Hestad KA, Tonseth S, Stoen CD, etal. Raised plasma levels of tumor necrosis factor alpha in patients with depression: normalization during electroconvulsive therapy. J ECT 2003 19 183-188
36. Tuglu C, Kara SH, Caliyurt O, etal. Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder. Psychopharmacology (Berl) 2003 170 429-433
37. Haack M, Hinze-Selch D, Fenzel T, etal. Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis. J Psychiatr Res 1999 33 407-418
38. Kraus T, Haack M, Schuld A, etal. Body weight, the tumor necrosis factor system, and leptin production during treatment with mirtazapine or venlafaxine. Pharmacopsychiatry 2002 35 220-225
39. Song C, Horrobin DF, Leonard BE. The comparison of changes in behavior, neurochemistry, endocrine, and immune functions after different routes, doses and durations of administrations of IL-1beta in rats. Pharmacopsychiatry. 2006 39 88-99
40. Asai K, Hiki N, Mimura Y, etal. Gender differences in cytokine secretion by human peripheral blood mononuclear cells: role of estrogen in modulating LPS-induced cytokine secretion in an ex vivo septic model. Shock 2001 16 340-343
41. Rook GA, Zumla A. Gulf War syndrome: is it due to a systemic shift in cytokine balance towards a Th2 profile? Lancet 1997 349 1831-1833
42. Rothermundt M, Arolt V, Fenker J, etal. Different immune patterns in melancholic and non-melancholic major depression. Eur Arch Psychiatry Clin Neurosci 2001 251 90-97 (Pubitemid 32488037)
43. Kubera M, Lin AH, Kenis G, etal. Anti-Inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio. J Clin Psychopharmacol 2001 21 199-206
44. Merali Z, Brennan K, Brau P, etal. Dissociating anorexia and anhedonia elicited by interleukin-1beta: antidepressant and gender effects on responding for free chow and earned sucrose intake. Psychopharmacology (Berl) 2003 165 413-418
45. Yaron I, Shirazi I, Judovich R, etal. Fluoxetine and amitriptyline inhibit nitric oxide, prostaglandin E2, and hyaluronic acid production in human synovial cells and synovial tissue cultures. Arthritis Rheum 1999 4 2561-2568
46. Yirmiya R, Pollak Y, Barak O, etal. Effects of antidepressant drugs on the behavioral and physiological responses to lipopolysaccharide (LPS) in rodents. Neuropsychopharmacology 2001 24 531-544
47. Fang JQ, Aoki E, Yu Y, etal. Inhibitory effect of electroacupuncture on murine collagen arthritis and its possible mechanisms. In Vivo 1999 13 311-318
48. Jeong HJ, Hong SH, Nam YC, etal. The effect of acupuncture on proinflammatory cytokine production in patients with chronic headache: a preliminary report. Am J Chin Med 2003 31 945-954
49. Park MB, Ko E, Ahn C, etal. Suppression of IgE production and modulation of Th1/Th2 cell response by electroacupuncture in DNP-KLH immunized mice. J Neuroimmunol 2004 151 40-44
50. Tian L, Huang YX, Tian M, etal. Downregulation of electroacupuncture at ST36 on TNF-alpha in rats with ulcerative colitis. World J Gastroenterol 2003 9 1028-1033
51. Xu ZF, Wu GC, Cao XD. Effect of electroacupuncture on the expression of interlukin-1beta mRNA after transient focal cerebral ischemia. Acupunct Electrother Res 2002 27 29-35
52. Schuld A, Schmid DA, Haack M, etal. Hypothalamo-pituitary-adrenal function in patients with depressive disorders is correlated with baseline cytokine levels, but not with cytokine responses to hydrocortisone. J Psychiatr Res 2003 37 463-470
53. Smith RS. The macrophage theory of depression. Med Hypoth 1991 35 298-306
54. Han JS, Chen XH, Sun SL, etal. Effect of low- and high-frequency TENS on Met-enkephalin-Arg-Phe and dynorphin A immunoreactivity in human lumbar CSF. Pain 1991 47 295-298
55. Le Bars D, Dickerson AH, Besson JM. Diffuse noxious inhibitory controls: effects on dorsal horn convergent neurons in the rat. Pain 1979 6 305-327
56. Nickel T, Sonntag A, Backmund M, etal. Depression during therapy with interferon alphahow long should an antidepressant treatment last? Pharmacopsychiatry 2005 38 102-104
57. Song Y, Zhou D, Fan J, etal. Effects of electroacupuncture and fluoxetine on the density of GTP-binding-proteins in platelet membrane in patients with major depressive disorder. J Affect Disord 2007 98 253-257